Saroja Pharma Industries
add_icon

Saroja Pharma Industries

35.00
0.00
(0.00%)
Market Cap
14.07 Cr
PE Ratio
13.62
Volume
0.00
Day High - Low
- - -
52W High-Low
60.00 - 32.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
14.07 Cr
EPS
2.57
PE Ratio
13.62
PB Ratio
0.90
Book Value
38.99
EBITDA
3.00
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
6.60
Debt to Equity
0.50
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,464.90
#1 1,49,084.93
64.43
13,387.50
6.91
#1 2,096
11.97
48.15
2,689.10
79,711.60
44.64
14,825.80
12.13
1,251
59.61
35.69
3,425.70
37,631.31
57.10
4,853.20
10.61
546
-19.05
54.90
6,526.00
33,427.82
59.97
2,393.10
12.83
289
121.77
60.04
489.70
24,705.12
33.95
4,664.30
10.33
555
36.07
65.76
1,604.00
21,877.44
41.96
8,365.80
7.84
697
1.73
45.78
6,581.00
19,375.62
#1 31.94
5,692.40
#1 18.99
499
39.62
61.11
450.65
16,340.29
43.57
7,285.40
14.16
331
#1 189.13
63.41
1,506.60
15,618.26
34.70
2,292.50
18.24
405
7.58
44.66
3,573.60
15,468.56
40.64
#1 15,339.40
10.81
479
2.99
40.57
Growth Rate
Revenue Growth
31.78 %
Net Income Growth
11.11 %
Cash Flow Change
12.75 %
ROE
10.00 %
ROCE
9.05 %
EBITDA Margin (Avg.)
-18.01 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
37
56
50
41
54
0
Expenses
35
54
48
38
51
0
EBITDA
1
2
3
3
3
0
Operating Profit %
4 %
4 %
5 %
6 %
5 %
0 %
Depreciation
0
0
0
0
0
0
Interest
0
1
1
1
1
0
Profit Before Tax
1
2
2
1
1
0
Tax
0
0
0
0
0
0
Net Profit
1
1
1
1
1
0
EPS in ₹
2.69
3.96
3.61
2.49
2.57
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
8
16
21
27
40
Fixed Assets
0
0
2
3
3
Current Assets
8
15
16
18
27
Capital Work in Progress
0
0
2
6
9
Investments
0
0
0
0
0
Other Assets
8
15
17
18
28
Total Liabilities
8
16
21
27
40
Current Liabilities
6
10
13
9
23
Non Current Liabilities
1
2
3
3
1
Total Equity
1
4
5
15
16
Reserve & Surplus
1
4
2
11
12
Share Capital
0
0
3
4
4

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-0
0
0
0
0
Investing Activities
-0
-0
-5
-5
-3
Operating Activities
-1
-4
2
1
1
Financing Activities
1
4
3
4
2

Share Holding

% Holding
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Sept 2025
Promoter
73.02 %
73.02 %
73.02 %
73.02 %
73.02 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.32 %
24.08 %
24.04 %
24.00 %
23.60 %
Others
2.67 %
2.91 %
2.94 %
2.98 %
3.38 %
No of Share Holders
641
506
438
422
435

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 62.70 58.25
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 58.45 54.00
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 45.00 41.90
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 43.15 41.25

Technical Indicators

RSI(14)
Neutral
38.64
ATR(14)
Less Volatile
1.41
STOCH(9,6)
Neutral
34.78
STOCH RSI(14)
Neutral
64.95
MACD(12,26)
Bearish
-0.12
ADX(14)
Strong Trend
26.50
UO(9)
Bearish
40.05
ROC(12)
Downtrend And Accelerating
-12.50
WillR(14)
Neutral
-66.67